UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
DC 20549
____________
Amendment
No. 1
on
FORM
8-K/A
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the
Securities
Exchange Act of 1934
Date of
Report (date of earliest event reported):
June 1, 2005
Altair
Nanotechnologies Inc.
(Exact
Name of Registrant as Specified in its Charter)
|
Canada |
|
1-12497 |
|
33-1084375 |
|
(State
or other jurisdiction of |
|
(Commission |
|
(IRS
Employer |
|
incorporation or
organization) |
|
File Number) |
|
Identification
No.) |
|
204
Edison Way |
|
|
|
Reno,
NV |
|
89502 |
|
(Address
of Principal Executive Offices) |
|
(Zip
Code) |
Registrant's
Telephone Number, Including Area Code:
(Former
name, former address, and formal fiscal year, if changed since last
report)
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General
Instruction A.2. below):
[ ]
Written communications pursuant to Rule 425 under the Securities Act
(17 CFR
230.425)
[ ]
Soliciting material pursuant to Rule 14a-12 under the Exchange
Act (17 CFR
240.14a-12)
[ ]
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
Act (17 CFR 240.14d-2(b))
[ ]
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
Act (17 CFR 240.13e-4(c)
Item
5.02 Departure of Directors or Principal Officers; Election of Directors;
Appointment for Principal Officers.
As
permitted by Item 5.02 of a Current Report on Form 8-K, Rudi E. Moerck has
submitted a letter related to the Form 8-K filed by Altair Nanotechnolgies Inc.
(the “Company”) on May 25, 2005 and requested that the Company filed it on an
amendment to that Form 8-K. A copy of such letter is attached as Exhibit 99.1
hereto.
Management
has reviewed the letter, disagrees with many of its claims and continues to
stand behind its public statements and business plan. Mr. Moerck’s
arguments have been addressed directly or indirectly in various releases,
reports and conference calls by management. For these reasons, and
management’s desire to remain focused on developing the business of the Company,
management has determined not to respond to its specific arguments or
allegations.
Item
9.01 Financial Statements and Exhibits
(c)
Exhibits.
The
letter included in this Item 9.01 was was drafted by, or on behalf of, Rudi E.
Moerck. The Company expressly disclaims any responsibility for, or the accuracy
of, the information in the letter included in the Item 9.01 and is filing such
letter solely in order to satisfy a requirement under Item 5.02 of Form 8-K.
99.1
Letter from Mr. Moerck to Mr. Gotcher dated June 1, 2005
SIGNATURES
Pursuant
to the requirements of the Securities Exchange of 1934, the registrant has duly
caused this report to be signed on its behalf by the undersigned hereunto duly
authorized.
| |
|
|
| |
Altair
Nanotechnologies, Inc. |
|
|
|
| Dated: June 3, 2005 |
By: |
/s/ Alan Gotcher |
| |
Alan
Gotcher |
| |
Chief Executive
Officer |
4